CONMED Corporation

NYSE CNMD

CONMED Corporation Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2024: 4.88

CONMED Corporation Interest Coverage Ratio is 4.88 for the Trailing 12 Months (TTM) ending September 30, 2024, a 528.16% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • CONMED Corporation Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2023 was 0.78, a 174.22% change year over year.
  • CONMED Corporation Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2022 was -1.05, a -148.79% change year over year.
  • CONMED Corporation Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2021 was 2.15, a 88.62% change year over year.
  • CONMED Corporation Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2020 was 1.14, a -21.42% change year over year.
Key data
Date Interest Coverage Ratio Debt to Equity Ratio Interest Expense To Sales Inventory Turnover Ratio
Market news
Loading...
NYSE: CNMD

CONMED Corporation

CEO Mr. Curt R. Hartman
IPO Date July 23, 1987
Location United States
Headquarters 11311 Concept Boulevard
Employees 4,000
Sector Health Care
Industries
Description

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Similar companies

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

LIVN

LivaNova PLC

USD 47.63

0.66%

GMED

Globus Medical, Inc.

USD 88.18

1.15%

STE

STERIS plc

USD 207.57

0.10%

SIBN

SI-BONE, Inc.

USD 15.70

-3.27%

ITGR

Integer Holdings Corporation

USD 138.83

2.72%

ATEC

Alphatec Holdings, Inc.

USD 11.12

2.21%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

IRTC

iRhythm Technologies, Inc.

USD 99.01

4.67%

ANIK

Anika Therapeutics, Inc.

USD 15.58

-2.14%

GKOS

Glaukos Corporation

USD 147.95

-2.58%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

StockViz Staff

January 15, 2025

Any question? Send us an email